Related Experiment Videos
Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures
P S Charifson1, J J Corkery, M A Murcko
1Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, Massachusetts 02139-4242, USA. paulc@vpharm.com
Journal of Medicinal Chemistry
|December 22, 1999
Summary
Consensus scoring, combining multiple computational methods, significantly improves the identification of active enzyme inhibitors. This approach enhances accuracy and reduces false positives in drug discovery.
Area of Science:
- Computational chemistry
- Drug discovery
- Biochemistry
Background:
- Identifying effective enzyme inhibitors is crucial for drug development.
- Individual computational scoring functions have limitations in accurately predicting inhibitor activity.
- Enzyme targets include p38 MAP kinase, inosine monophosphate dehydrogenase, and HIV protease.
Purpose of the Study:
- To evaluate the effectiveness of combining multiple scoring functions using a consensus approach.
- To assess the ability of consensus scoring to discriminate between active and inactive enzyme inhibitors.
- To analyze the performance of different docking methods and scoring functions.
Main Methods:
- Extensive computational study involving docking 3D structures.
- Utilized two docking methods and thirteen scoring functions.
- Employed an intersection-based consensus approach for scoring function combination.
Main Results:
- Consensus scoring significantly enhanced the discrimination between active and inactive enzyme inhibitors.
- The study identified specific scoring functions that perform well individually and in combination.
- Consensus scoring dramatically reduced false positives compared to individual scoring functions.
Conclusions:
- Combining scoring functions via consensus approach is a powerful strategy for improving hit-rates in drug discovery.
- This method offers a more reliable way to identify potential drug candidates.
- The findings provide valuable insights for optimizing computational drug screening protocols.